Overview of Research Program Timeline. The following timeline represents the Company’s best estimate for achieving site initiation, follow-up and study reports. In order to maintain maximum flexibility of the Research Program, the timeline and associated Deliverables, Milestones and Payments may be revised by mutual agreement of the Parties. Timeline for Site Initiation, Follow-up, and Study Report for Approval Track Clinical Trial of ON 00000.Xx in High Risk Myelodysplastic Syndromes (MDS) Patients Refractory to Hypomethylating Agents.
Appears in 6 contracts
Samples: Definitive Agreement (Onconova Therapeutics, Inc.), Definitive Agreement (Onconova Therapeutics, Inc.), Third Amendment to Agreement (Onconova Therapeutics, Inc.)
Overview of Research Program Timeline. The following timeline represents the Company’s best estimate for achieving site initiation, follow-up and study reports. In order to maintain maximum flexibility of the Research Program, the timeline and associated Deliverables, Milestones and Payments may be revised by mutual agreement of the Parties. Timeline for Site Initiation, ; Follow-up, and -and-Study Report for Approval Track Track-Clinical Trial of ON 00000.Xx in High Risk Myelodysplastic Syndromes (MDS) Patients Refractory to Hypomethylating Agents.
Appears in 2 contracts
Samples: Second Amendment to Definitive Agreement (Onconova Therapeutics, Inc.), Second Amendment to Definitive Agreement (Onconova Therapeutics, Inc.)
